Specifically, participants with NAFLD had significantly higher BMI (34.50 vs. 24.31 kg/m2, P < 0.001), elevated TG levels (177.47 vs. 88.11 mg/dL, P < 0.001), increased ALT (31.68 vs. 20.31 U/L, P < 0.001), higher AST (26.81 vs. 22.83 U/L, P < 0.001), and higher GGT levels (37.63 vs. 17.87 U/L, P < 0.001), as well as higher fasting glucose (105.46 vs. 91.04 mg/dL, P < 0.001) and total cholesterol concentrations (197.75 vs. 179.23 mg/dL, P < 0.001). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.